Aug. 1 at 8:05 PM
$IXHL 🎢 🥳
08-01-2025
📚
Today’s Trading/Stocks Lesson
Small History Lesson for another BioTech Stock that I experienced not too long ago.
(along with “my” observations in the IXHL msg boards over the last 2 weeks)
🔬 Example: Scholar Rock -
$SRRK
Trading price before data release: Under
$8/share Type of event: Strong non–COVID Phase 3 data, dramatic move
📉 Pre‑catalyst performance:
Shares had been drifting near
$7–8 for months amid general biotech malaise—even though fundamentals were stable
📈 Catalyst and rebound:
On October 7, 2024, Scholar Rock announced impressive Phase 3 results for apitegromab in spinal muscular atrophy (SMA): improved motor function in treated patients vs placebo. The news drove the stock up by 300%, pushing the share price from ~
$7.40 to above
$30 in a single session
🧠 Why it mirrors IXHL’s setup:
* Under ~
$8 going into data release
* Strong Phase 3 efficacy data (SMA)
* “Sell‑the‑news” style volatility: the stock was quiet before; news sparked a massive re-rating once market fully absorbed the significance
* Recover >300% within session once investor focus shifted to clinical validation and approval trajectory
✅ Key Takeaway:
Scholar Rock demonstrates how a biotech trading under
$8/share can deliver huge upside from positive trial results—even if the stock initially LAGS.
Once the market fully digests the value-driving news (especially regulatory designations and registration prospects), the rebound can be explosive.
🔥 🎢 IXHL is in a similar position: strong data already reported, with major near‐term milestones ahead—creating a credible setup for a sharp re-rating.
📌📚
“My observations in the IXHL msg boards”
👇 👇
It's honestly bizarre how some uneducated traders seem baffled when a good stock experiences normal fluctuations. They treat any dip like it's a sign of doom, as if volatility is some kind of glitch in the system — not realizing that even strong companies don't move in straight lines.
Stocks, even the best ones, are subject to market psychology, macroeconomic shifts, profit-taking, and algorithmic trading. Apple, Amazon, Microsoft — they’ve all had plenty of corrections on the way to all-time highs.
NO, I am not implying in any way that IXHL is relatable in Size or Strength to Apple/Amazon, but purely for context.
(For you Trolls that were ANXIOUSLY waiting to POUNCE!) 🙄🤦♂️
Expecting a good stock to only go up is like expecting the weather to be sunny every single day. ESPECIALLY in the BioTech sector. Volatility isn’t a flaw. It’s part of the game. And ironically, it’s those ups and downs that create opportunity.
What’s really wild is how some amateur traders act like once a stock dips, it’s permanently broken — like the entire business just evaporated overnight. It shows a complete misunderstanding of how markets work.
They equate short-term price movement with long-term value, not realizing that price is what you pay — value is what you get.
They think a dip means “it’ll never go back up,” when in reality, that kind of thinking is exactly why they consistently buy high and sell low.
Again, “I” know what I have in IXHL,
Read my other Due Diligence posts!!
Educate yourself!
Be CONFIDENT in what you own or MOVE ON from it!
Again, IF you wouldn’t own it for 5 years, you shouldn’t own it for 5 MINUTES!!
I’ll be doing more Due Diligence, READING and continuing to educate myself like I am ALWAYS doing!
What will YOU 🫵 be doing tonight and tomorrow? Reading?
Or partying and HOPING for your next “Get Rich Overnight Stock”??!! 🤔 🫠
Stocks and Investing does NOT Reward the LAZY and IMPATIENT!!! 😉
Have a great weekend everyone! 🤙
